Hemodynamic and humoral conditions in stepwise reduction of pulmonary blood flow during venoarterial bypass in awake goats

ASAIO Journal

Volumn 43, Issue 5, 1997, Pages

  Takewa, Yoshiaki ^a   Tatsumi, Eisuke ^a   Taenaka, Yoshiyuki ^a   Eya, Kazuhiro ^a   Nakatani, Takeshi ^a   Nishimura, Takashi ^a   Sohn, Young Sang ^a   Masuzawa, Toru ^a   Wakisaka, Yoshinari ^a   Nakamura, Makoto ^a   Endo, Seiko ^a   Takano, Hisateru ^a   Kitamura, Soichiro ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL EQUIPMENT; CARDIOVASCULAR SURGERY; DRUG INFUSION; IMPLANTS (SURGICAL); RESPIRATORY MECHANICS;

GOATS; PULMONARY ARTERY; VENOARTERIAL BYPASS;

HEMODYNAMICS;

ADRENALIN; NORADRENALIN; PROSTAGLANDIN E2; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; ARTERIOVENOUS SHUNT; CONFERENCE PAPER; EXTRACORPOREAL CIRCULATION; GOAT; HEMODYNAMIC PARAMETERS; LUNG BLOOD FLOW; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMIC VASCULAR RESISTANCE;

EID: 0031239268     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199709000-00030     Document Type: Conference Paper

References (22)

1. Muehrcke DD, McCarthy PM, Stewart RW, et al.: Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg 61: 684-691, 1996.
2. Ichiba S, Bartlett RH: Current status of extracorporeal membrane oxygenation for severe respiratory failure. Artif Organs 20:120-123, 1996.
3. Kolla S, Lee WA, Hirschl RB, Bartlett RH: Extracorporeal life support for cardiovascular support in adults. ASAIO J 42: M809-M819, 1996.
4. Ratliff JL, Hill JD, Fallat RJ, Parrot J, Tucker HJ: Complications associated with membrane lung support by venoarterial perfusion. Ann Thorac Surg 19: 537-539, 1975.
5. Bakhle YS, Vane JR: Pharmacokinetic function of the pulmonary circulation. Physiol Rev 54: 1007-1045, 1974.
6. Takano H, Nakatani T, Taenaka Y: Clinical experience with ventricular assist systems in Japan. Ann Thorac Surg 55: 250-256, 1993.
7. Tatsumi E, Eya K, Taenaka Y, et al.: Long-term cardiopulmonary support with a composite artificial heart-lung system. ASAIO J 41: M557-M560, 1995.
8. Akasu H, Anazawa T: Development of a membrane oxygenator using novel polyolefin hollow fibers with blind-ended micropores. Jpn J Biomater 8: 141-147, 1990.
9. Eya K, Tatsumi E, Taenaka Y, et al.: Development of a membrane oxygenator for long-term respiratory support and its experimental evaluation in prolonged ECMO. ASAIO J 42: M832-M836, 1996.
10. Downing SW, Edmunds LH Jr: Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 54: 1236-1243, 1992.
11. Eya K, Tatsumi E, Taenaka Y, et al.: Importance of metabolic function of the natural lung evaluated by prolonged exclusion of the pulmonary circulation. ASAIO J 42: M805-M809, 1996.
12. Ferreira SH, Vane JR: Prostaglandins: their disappearance from and release into the circulation. Nature 216: 868-873, 1967.
13. Cedro A, Herbaczynska-Cedro K: Increased blood level of prostaglandin-like substances during cardiopulmonary bypass in the dog. Cardiovasc Res 12: 516-522, 1978.
14. Pitt BR, Gillis CN, Hammond GL: Influence of the lung on arterial levels of endogenous prostaglandins E and F. J Appl Physiol 50: 1161-1167, 1981.
15. Faymonville ME, Deby Dupont G, Larbuisson R, et al.: Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 91: 858-866, 1991.
16. Moncada S, Korbut R, Bunting S, Vane JR: Prostacyclin is a circulating hormone. Nature 273: 767-768, 1978.
17. Feddersen K, Aurell M, Delin K, Haggendal J, Aren C, Radegran K: Effects of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine-vasopressin. Acta Anaesthesiol Scand 29: 224-230, 1985.
18. Townsend GE, Wynands JE, Whalley DG, Wong P, Bevan DR: Role of renin-angiotensin system in cardiopulmonary bypass hypertension. Can Anaesth Soc J 31: 160-165, 1984.
19. Biron P, Campeau L, David P: Fate of angiotensin I and II in the human pulmonary circulation. Am J Cardiol 24: 544-547, 1969.
20. Ginn R, Vane JR: Disappearance of catecholamines from the circulation. Nature 219: 740-742, 1968.
21. Reves JG, Karp RB, Buttner EE, et al.: Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 66: 49-55, 1982.
22. Schaff HV, Mashburn JP, McCarthy PM, Torres EJ, Burnett JC: Natriuresis during and early after cardiopulmonary bypass: relationship to atrial natriuretic factor, aldosterone, and antidiuretic hormone. J Thorac Cardiovasc Surg 98: 979-986, 1989.